Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface

Summary

The purpose of this open, multicenter phase II trial is to confirm the tolerance and evaluate the efficacy of the SclerFIX product, an allograft of umbilical cord lining membrane, in reinforcement of scleral thinning in patients who underwent eye tumor exeresis.

Timeline

Start

2022-07-04

Primary completion

2024-02-21

Completion

2024-02-21

Outcome

Outcome not reported

Stopped (Enrollment): “Low accrual rate”

Drugs

Indications